Technical Analysis for AMAM - Ambrx Biopharma Inc.

Grade Last Price % Change Price Change
D 18.35 -8.30% -1.66
AMAM closed down 8.3 percent on Wednesday, August 4, 2021, on 2.04 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical AMAM trend table...

Date Alert Name Type % Chg
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish -8.30%
Multiple of Ten Bullish Other -8.30%
Outside Day Range Expansion -8.30%
20 DMA Resistance Bearish -7.79%
Pocket Pivot Bullish Swing Setup -7.79%
Multiple of Ten Bearish Other -7.79%
Multiple of Ten Bearish Other -6.14%
Fell Below 20 DMA Bearish -8.71%
Older End-of-Day Signals for AMAM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1 ATR about 17 hours ago
Fell Below Lower Bollinger Band about 19 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
2x Volume Pace about 20 hours ago
1.5x Volume Pace about 20 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. These include next generation antibody drug conjugates (ADCs), bispecifics, targeted immuno-oncology therapies, novel cytokines to modulate the immune system, and long-acting therapeutic peptides for metabolic and cardiovascular disease. Ambrx is advancing a robust portfolio of clinical and preclinical programs designed to optimize efficacy, safety and ease of use, in multiple therapeutic areas, including its lead product candidate ARX788. In addition, the company has clinical collaborations with Bristol Myers Squibb, Astellas, BeiGene, Sino Biopharma, Elanco and NovoCodex, for drug candidates generated using Ambrx technology.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Immunology Health Sciences Pharmacy Cancer Immunotherapy Sutro Biopharma Oncology Therapies

Is AMAM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.8702
52 Week Low 14.94
Average Volume 52,158
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 20.78
10-Day Moving Average 20.44
Average True Range 1.69
ADX 17.33
+DI 21.49
-DI 22.87
Chandelier Exit (Long, 3 ATRs) 17.79
Chandelier Exit (Short, 3 ATRs) 23.13
Upper Bollinger Bands 23.09
Lower Bollinger Band 18.47
Percent B (%b) -0.03
BandWidth 22.22
MACD Line 0.42
MACD Signal Line 0.84
MACD Histogram -0.4137
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.90
Resistance 3 (R3) 21.08 20.42 20.48
Resistance 2 (R2) 20.42 19.77 20.33 20.33
Resistance 1 (R1) 19.38 19.37 19.05 19.20 20.19
Pivot Point 18.72 18.72 18.55 18.63 18.72
Support 1 (S1) 17.68 18.07 17.35 17.50 16.51
Support 2 (S2) 17.02 17.67 16.93 16.37
Support 3 (S3) 15.98 17.02 16.23
Support 4 (S4) 15.80